| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Grace Therapeutics, Inc.'s insiders have accumulated 295,962 shares worth roughly $608K on balance. In the past 30 days, 1 insider bought and 0 sold. Recent activity has leaned to the buy side.
Leading the buying is Opaleye Management Inc. (10% Owner), now holding an estimated $5.6M in GRCE.
Classified under Biotechnology (Health Care sector), GRCE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.94M | $5.57M | +169.1K | |
| CEO | 121.4K | $259.7K | - | |
| Other | 54.7K | - | - | |
| VP | 35.8K | - | - | |
| Other | 33.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 71,065 | $1.92 | $136,177.72 | +2.5% | - | - | |
| Oct 12, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 14,632 | $2.03 | $29,682.81 | +0.5% | - | - | |
| Oct 5, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 60,490 | $2.05 | $123,819.14 | +2.2% | - | - | |
| Sep 29, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 7,849 | $2.09 | $16,404.41 | +0.3% | - | - | |
| Sep 23, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 15,089 | $2.10 | $31,686.90 | +0.5% | - | - | |
| Sep 9, 2026 | Kohli Prashant | Chief Executive Officer | Buy | 100,000 | $2.14 | $214,000.00 | +468.2% | - | - | |
| Sep 9, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 15,229 | $2.09 | $31,895.66 | +0.6% | - | - | |
| Aug 14, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 11,608 | $2.09 | $24,206.16 | +0.4% | - | - | |
| Sep 25, 2023 | Kavuru Vimal | Director, 10% Owner | Buy | 676,371 | $1.85 | $1,249,933.61 | +132.2% | +26.4% | +43.8% | |
| Aug 31, 2023 | Olds Donald | Director | Buy | 381 | $2.05 | $781.05 | New | -0.5% | +27.2% |